0DZ0 Stock Chart & Stats
kr410.00
-kr1.00(-0.24%)
At close: 4:00 PM EDT
kr410.00
-kr1.00(-0.24%)
Day’s Range― - ―
52-Week Rangekr236.00 - kr799.25
Previous CloseN/A
Volume5.39K
Average Volume (3M)1.79K
Market Cap
kr7.53B
Enterprise Valuekr9.84B
Total Cash (Recent Filing)kr264.74M
Total Debt (Recent Filing)kr7.78M
Price to Earnings (P/E)42.5
Beta1.13
Next Earnings
Sep 10, 2026EPS Estimate
-1.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.72
Shares Outstanding17,402,480
10 Day Avg. Volume768
30 Day Avg. Volume1,786
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ChemoMetec A/S News
0DZ0 FAQ
What was ChemoMetec A/S’s price range in the past 12 months?
ChemoMetec A/S lowest share price was kr236.00 and its highest was kr799.25 in the past 12 months.
What is ChemoMetec A/S’s market cap?
ChemoMetec A/S’s market cap is kr7.53B.
When is ChemoMetec A/S’s upcoming earnings report date?
ChemoMetec A/S’s upcoming earnings report date is Sep 10, 2026 which is in 31 days.
How were ChemoMetec A/S’s earnings last quarter?
ChemoMetec A/S released its earnings results on Apr 30, 2026. The company reported kr4.85 earnings per share for the quarter, beating the consensus estimate of kr3.66 by kr1.19.
Is ChemoMetec A/S overvalued?
According to Wall Street analysts ChemoMetec A/S’s price is currently Overvalued.
Does ChemoMetec A/S pay dividends?
ChemoMetec A/S does not currently pay dividends.
What is ChemoMetec A/S’s EPS estimate?
ChemoMetec A/S’s EPS estimate is -1.15.
How many shares outstanding does ChemoMetec A/S have?
ChemoMetec A/S has 17,402,480 shares outstanding.
What happened to ChemoMetec A/S’s price movement after its last earnings report?
ChemoMetec A/S reported an EPS of kr4.85 in its last earnings report, beating expectations of kr3.66. Following the earnings report the stock price went up 0.329%.
Which hedge fund is a major shareholder of ChemoMetec A/S?
Currently, no hedge funds are holding shares in GB:0DZ0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ChemoMetec A/S
Headquartered in Allerød, Denmark, and established in 1997, ChemoMetec A/S focuses on the design, production, and worldwide distribution of analytical instruments for cell enumeration and analysis. Their sophisticated solutions are utilized across diverse fields, including cell-based therapeutics, oncology and stem cell research, pharmaceutical development and manufacturing, along with quality assurance for animal semen and beer. The company's product offerings feature a range of NucleoCounter devices, such as the NC-3000 advanced image cytometer, the NC-250 automated cell analyzer, and the consistent NC-202 and NC-200 automated cell counters for viability assessment. Specialized counters include the NucleoCounter SP-100 for automated sperm cell analysis in animal production, the SCC-100 for measuring somatic cells in milk samples, and the YC-100 for total count and viability of yeast cells. Beyond equipment, they also supply vital consumables like cassettes and reagents, various accessories such as software and cables, and offer extensive service and validation plans.